| UHC Surest Medical and Drug | Itvisma® (Onasemnogene Abeparvovec-Brve) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Itvisma® (Onasemnogene Abeparvovec-Brve) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-07-01 |
| UHC Commercial Medical & Drug | Itvisma® (Onasemnogene Abeparvovec-Brve) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-07-01 |
| UHC Medicaid Medical & Drug | Adakveo® (Crizanlizumab-Tmca) – Community Plan Medical Benefit Drug Policy | 2026-07-01 |
| UHC Medicaid Medical & Drug | Adzynma (ADAMTS13, Recombinant-Krhn) – Community Plan Medical Benefit Drug Policy | 2026-07-01 |
| UHC Medicaid Medical & Drug | Bariatric Surgery – Community Plan Medical Policy | 2026-07-01 |
| UHC Medicaid Medical & Drug | Breast Reduction Surgery – Community Plan Medical Policy | 2026-07-01 |
| UHC Medicaid Medical & Drug | Briumvi® (Ublituximab-Xiiy) – Community Plan Medical Benefit Drug Policy | 2026-07-01 |
| UHC Medicaid Medical & Drug | Carrier Testing Panels for Genetic Diseases – Community Plan Medical Policy | 2026-07-01 |
| UHC Medicaid Medical & Drug | Catheter Ablation for Atrial Fibrillation – Community Plan Medical Policy | 2026-07-01 |